<DOC>
	<DOCNO>NCT03086252</DOCNO>
	<brief_summary>This pilot study evaluate safety administration red blood cell transfusion request patient base symptom instead level hemoglobin treatment chronic anemia patient blood disorder .</brief_summary>
	<brief_title>Patient-Driven Transfusion Thresholds Hematological Disorders : A Pilot Study</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To assess feasibility safety red blood cell transfusion time subject request base symptomatic anemia . SECONDARY OBJECTIVES : I . To define patient-driven red blood cell transfusion ( RBCT ) threshold compare median hemoglobin ( hgb ) time subject request RBCT standard threshold hgb &lt; 8 g/dL . II . To compare number red blood cell ( RBC ) unit transfuse frequency transfusion time subject request RBCT study period number RBC unit receive frequency use standard threshold hemoglobin &lt; 8 g/dL comparable period prior enrollment . III . To compare quality life ( QoL ) score subject request RBCT score obtain time hgb 8 +/- 0.5 g/dL . OUTLINE : Patients undergo RBCT base perception and/or presence anemia symptom 6 month . After completion study treatment , patient follow 30 day .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Hematologic Neoplasms</mesh_term>
	<criteria>Diagnosed hematological malignancy marrow failure syndrome limit : aplastic anemia , myelodysplastic syndrome leukemia Chronic transfusiondependent anemia exposure least 5 RBCT Interested reduce transfusion exposure Willing sign inform consent Recent acute bleed require intervention le 24 hour Hemoglobin level &lt; 6 g/dL Acute leukemia receive induction chemotherapy Any patient know ischemic heart disease , history congestive heart failure , history stroke , cardiac arrhythmia patient require medication medical device Oxygen dependent Oxygen saturation 92 % room air Receiving erythropoietin stimulate agent Thalassemia major sickle cell disease require blood transfusion Undergoing major surgery Hemolytic anemia Coagulopathies include disseminate intravascular coagulation ( DIC ) , receive anticoagulant antiplatelet agent Diagnosed chronic obstructive pulmonary disease ( COPD ) oxygen dependent Pregnancy Participation therapeutic clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>